<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0007">
 <label>7</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Spring</surname>
    <given-names>LM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wander</surname>
    <given-names>SA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zangardi</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Bardia</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>CDK 4/6 inhibitors in breast cancer: current controversies and future directions</article-title>. 
  <source>Curr Oncol Rep</source>
  <year>2019</year>;
  <volume>21</volume>:
  <fpage>25</fpage>.
  <pub-id pub-id-type="pmid">30806829</pub-id>
 </mixed-citation>
</ref>
